Logo-npj

J Nephropharmacol. 2023;12(1): e10519. doi: 10.34172/npj.2022.10519

Review

Recurrence of rare disease after kidney transplant

Farahnoosh Farnood ORCID, Seyyedeh Mina Hejazian ORCID, Kamal Boostani ORCID, Alireza Mardomi ORCID, Mohammadreza Ardalan * ORCID

Cited by CrossRef: 1

1- Bartoszewicz M, Prokop P, Kosieradzki M, Fiedor P. Are Current Educational and Therapeutic Programs, Directed at Rare Disease Transplant Candidates and Recipients, Sufficient to Support Them on the Path From Diagnosis to Life After Allogenic Transplantation?—Recommendations for Member State Policymakers. Transplantation Proceedings. 2024;56(4):907 [Crossref]